Submission of Annual Secretarial Compliance Report for the financials year ended March 31, 2026
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services Limited has filed its Annual Secretarial Compliance Report for FY 2025-26, as mandated under SEBI LODR Regulation 24A. The report was prepared by R&A Associates, Practicing Company Secretaries, after examining compliance across SEBI regulations including LODR, SAST, PIT, and Depositories Regulations. The report shows zero current non-compliance violations, with all 13 compliance checkpoints marked as compliant. Two past observations from the previous year regarding delayed XBRL filings for Q3 December 2024 (investor grievance statement and corporate governance report) have been resolved, with the company strengthening its internal compliance mechanism. No actions were taken by SEBI or stock exchanges against the company during the review period.
A clean secretarial compliance report with resolved historical issues indicates improved governance practices, which is positive for investor confidence in MEDPLUS stock. The absence of any SEBI or stock exchange actions reinforces regulatory compliance standing.